PWZ-029

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NamePWZ-029
Drug Alias NamePWZ-029
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action +[1N/A
TargetsGamma-aminobutyric acid A receptor alpha-5
Therapy Area/IndicationsCognition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Belgrade
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Belgrade
Active IndicationsN/A
Inactive IndicationsCognition Disorders

Other Information

ATC CodeN/A
Related LinksN/A